Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19198
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTraylor, Matthew-
dc.contributor.authorRutten-Jacobs, Loes C A-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorHolliday, Elizabeth G-
dc.contributor.authorLevi, Chris-
dc.contributor.authorBevan, Steve-
dc.contributor.authorMalik, Rainer-
dc.contributor.authorBoncoraglio, Giorgio-
dc.contributor.authorSudlow, Cathie-
dc.contributor.authorRothwell, Peter M-
dc.contributor.authorDichgans, Martin-
dc.contributor.authorMarkus, Hugh S-
dc.date2016-
dc.date.accessioned2018-09-13T00:21:11Z-
dc.date.available2018-09-13T00:21:11Z-
dc.date.issued2016-
dc.identifier.citationStroke 2016; 47(5): 1174-9-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19198-
dc.description.abstractWhite matter hyperintensities (WMH) are increased in patients with lacunar stroke. Whether this is because of shared pathogenesis remains unknown. Using genetic data, we evaluated whether WMH-associated genetic susceptibility factors confer risk of lacunar stroke, and therefore whether they share pathogenesis. We used a genetic risk score approach to test whether single nucleotide polymorphisms associated with WMH in community populations were associated with magnetic resonance imaging-confirmed lacunar stroke (n=1,373), as well as cardioembolic (n=1,331) and large vessel (n=1,472) Trial of Org 10172 in Acute Stroke Treatment subtypes, against 9,053 controls. Second, we separated lacunar strokes into those with WMH (n=568) and those without (n=787) and tested for association with the risk score in these 2 groups. In addition, we evaluated whether WMH-associated single nucleotide polymorphisms are associated with lacunar stroke, or in the 2 groups. The WMH genetic risk score was associated with lacunar stroke (odds ratio [OR; 95% confidence interval [CI]]=1.14 [1.06-1.22]; P=0.0003), in patients both with and without WMH (WMH: OR [95% CI]=1.15 [1.05-1.26]; P=0.003 and no WMH: OR [95% CI]=1.11 [1.02-1.21]; P=0.019). Conversely, the risk score was not associated with cardioembolic stroke (OR [95% CI]=1.03 [0.97-1.09]; P=0.63) or large vessel stroke (OR [95% CI]=0.99 [0.93,1.04]; P=0.39). However, none of the WMH-associated single nucleotide polymorphisms passed Bonferroni-corrected significance for association with lacunar stroke. Genetic variants that influence WMH are associated with an increased risk of lacunar stroke but not cardioembolic or large vessel stroke. Some genetic susceptibility factors seem to be shared across different radiological manifestations of small vessel disease.-
dc.language.isoeng-
dc.subjectcerebral small vessel diseases-
dc.subjectgenetic association studies-
dc.subjectgenetics-
dc.subjectleukoencephalopathies-
dc.subjectStroke, lacunar-
dc.titleGenetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke.-
dc.typeJournal Article-
dc.identifier.journaltitleStroke-
dc.identifier.affiliationDivision of Clinical Neurosciences, Neuroimaging Sciences and Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdomen
dc.identifier.affiliationDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdomen
dc.identifier.affiliationDepartment of Medical and Molecular Genetics, King's College London, London, United Kingdomen
dc.identifier.affiliationLaboratory of Neurobiology, Vesalius Research Center, VIB, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, University of Leuven, Leuven, Belgiumen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine and Public Health and Centre for Clinical Epidemiology and Biostatistics, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australiaen
dc.identifier.affiliationSchool of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australiaen
dc.identifier.affiliationDepartment of Neurology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationClinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, New Lambton Heights, NSW, Australiaen
dc.identifier.affiliationSchool of Life Science, University of Lincoln, Lincoln, United Kingdomen
dc.identifier.affiliationInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germanyen
dc.identifier.affiliationDepartment of Cerebrovascular Disease, IRCCS Istituto Neurologico Carlo Besta, Milan, Italyen
dc.identifier.affiliationStroke Prevention Research Unit, Nuffield Department of Neuroscience, University of Oxford, Oxford, United Kingdomen
dc.identifier.affiliationMunich Cluster for Systems Neurology (SyNergy), Munich, Germanyen
dc.identifier.doi10.1161/STROKEAHA.115.011625-
dc.identifier.orcid0000-0002-6614-8417-
dc.identifier.pubmedid27073246-
dc.type.austinJournal Article-
dc.type.austinMulticenter Study-
dc.type.austinResearch Support, N.I.H., Extramural-
local.name.researcherThijs, Vincent N
item.languageiso639-1en-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptNeurology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on May 10, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.